is phentermine a glp 1 receptor agonist Current Strategies in Managing Obesity Understanding Weight Loss Medications: GLP-1
Description
Currently, no pharmacotherapies are available for the treatment of NAFLD/NASH and the disease is managed by targeting lifestyle changes and treating cardiometabolic risk factors [61]

The prespecified selection criteria included: (1) RCTs reporting desired cardiovascular or renal outcomes

Hepatology 69 (6), 23182322

Diabetes and cancer: Risk, challenges, management and outcomes

Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
